BMO Capital Upgrades National Health Investors (NHI) to Market Perform
Tweet
Share
E-mailGet Alerts NHI Hot Sheet
Price: $71.47 +0.28%
Rating Summary:
8 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
8 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
BMO Capital analyst John Kim upgraded National Health Investors (NYSE: NHI) from Underperform to Market Perform with a price target of $71.00.
For an analyst ratings summary and ratings history on National Health Investors click here. For more ratings news on National Health Investors click here.
Shares of National Health Investors closed at $65.62 yesterday.
You May Also Be Interested In
- New Street Research Upgrades Micron Technology (MU) to Buy
- NHI Announces Second Quarter 2026 Results
- Johnson Rice Upgrades Core Laboratories (CLB) to Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
